Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Cash generated from core business operations
Latest
$-38.50M
↓ 15% vs avg
Percentile
P38
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-33.48M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-38.50M | -20.7% |
| 2024 | $-31.90M | -74.4% |
| 2023 | $-18.29M | +58.5% |
| 2022 | $-44.04M | +30.0% |
| 2021 | $-62.93M | -23.8% |
| 2020 | $-50.82M | -52.7% |
| 2019 | $-33.28M | -184.5% |
| 2018 | $-11.70M | -19.0% |
| 2017 | $-9.83M | - |